OCT 29, 2020 8:00 AM PDT

Cell types to targets: Single cell RNA-sequencing for drug discovery

Sponsored by: 10x Genomics
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract
Date:  October 29, 2020
Time: 8:00am (PDT),  11:00am (EDT),  4:00pm (CET)
 
What cell types cause and perpetuate disease? For many diseases, scientists only have guesses to this critical question. Single cell RNA-sequencing (scRNA-seq) presents a new opportunity to survey the full range of cells in a tissue and dissect how individual cell types change in their expression profiles, abundance, and interactions in the disease context. scRNA-seq can also reveal unexpected new subtypes or functional states related to disease.
 
In this webinar, Dr. Sarah Middleton, Computational Biologist at GlaxoSmithKline, will discuss how taking a cell type–first approach to understanding disease can be a powerful strategy to inform multiple steps of the drug discovery pipeline, from target identification to patient stratification. A key requirement for success of this strategy is accurate and deep cell-type classification, which remains challenging, especially for subtypes. Dr. Middleton will discuss how to alleviate these challenges both through computational approaches and integration of multiomic data types. Finally, she will discuss what is needed to scale up these approaches and make full use of the huge compendiums of single cell data now becoming available.
 
Learning Objectives
  • How scRNA-seq can be used in drug discovery and development
  • The challenges of cell subtype identification and how to address them with computational tools and multiomic data integration
  • The importance of automated analysis methods and pipelines, and pitfalls to avoid
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
Loading Comments...
Show Resources